Sunshine Biopharma Inc. (SBFM) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Sunshine Biopharma Inc.

    NASDAQ: SBFM · Real-Time Price · USD
    1.50
    -0.06 (-3.85%)
    At close: Sep 25, 2025, 3:55 PM
    1.45
    -3.56%
    After-hours: Sep 25, 2025, 07:19 PM EDT

    Sunshine Biopharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 34.87M 24.09M 4.35M 228.43K
    Cost of Revenue
    		 24.2M 15.75M 2.65M 117.83K
    Gross Profit
    		 10.67M 8.34M 1.7M 110.6K
    Operating Income
    		 -5.81M -4.79M -27M -2.44M
    Interest Income
    		 496K 811.97K 518.65K n/a
    Pretax Income
    		 -5.37M -4.11M -26.51M -12.44M
    Net Income
    		 -5.13M -4.51M -26.74M -12.44M
    Selling & General & Admin
    		 14.94M 10.83M 9.48M 1.87M
    Research & Development
    		 933.9K 1.86M 811.86K 672.21K
    Other Expenses
    		 610.62K 438.88K 80.4K 12.74K
    Operating Expenses
    		 16.48M 13.12M 10.37M 2.55M
    Interest Expense
    		 8.77K 137.31K 39.41K 328.82K
    Selling & Marketing Expenses
    		 940.28K 734.25K 578.09K n/a
    Cost & Expenses
    		 40.69M 28.88M 13.02M 2.67M
    Income Tax Expense
    		 -235K 395.17K 233.3K n/a
    Shares Outstanding (Basic)
    		 701.75K 12.16K 7.59K 1.31K
    Shares Outstanding (Diluted)
    		 701.75K 12.16K 7.59K 1.31K
    EPS (Basic)
    		 -7.32 -351.36 -3.52K -9.77K
    EPS (Diluted)
    		 -7.32 -351.36 -3.52K -9.52K
    EBITDA
    		 -5.15M -3.82M -26.45M -12.1M
    EBIT
    		 -5.36M -3.97M -26.47M -12.11M
    Depreciation & Amortization
    		 223.53K 149.15K 25.16K 12.74K

    Add to Watchlist